Frequency Therapeutics, Inc.
TAZ ACTIVATORS AND WNT AGONISTS FOR TREATING EAR DISORDERS

Last updated:

Abstract:

Provided are compositions and methods comprising a TAZ activator and a Wnt agonist for increasing proliferation of cochlear supporting cells or vestibular supporting cells, and related methods of treating inner ear hearing or balance disorders.

Status:
Application
Type:

Utility

Filling date:

7 Feb 2020

Issue date:

26 May 2022